Manufacturer:

Seattle Genetics

Name:

ADCETRIS

Category:

J Code

HCPCS:

J9042

NDC(s):

51144-0050-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

ADCETRIS is a Cancer drug manufactured by Seattle Genetics and administered via the Intravenous route of administration. The J Code: J9042 is aligned to the drug ADCETRIS.

Adcetris is an antibody-drug conjugate that targets tumors expressing the CD30 antigen, a common tumor protein in certain types of lymphoma. Adcetris is administered as an intravenous infusion with the dosage and frequency of treatment dependent on the type and stage of the cancer being treated. Adcetris is co-marketed by both Millennium Pharmaceuticals and Seattle Genetics. Patient assistance can be found here: https://www.seagensecure.com/patient/adcetris.